Thursday, October 30, 2014
Inquirer Daily News

Breast Cancer

  • More Top Stories
  • Latest News
Next month, Thomas G. Frazier will sit down with colleagues at Bryn Mawr Hospital's Comprehensive Breast Center and unseal the results of a blind study for Dune Medical's MarginProbe.
Q: How often should I be screened for breast cancer? A: Breast cancer is the second-leading cancer killer of women. Early detection with screening mammography is key because treatment can be started earlier in the course of the disease.
There are some people who are not uplifted by Breast Cancer Awareness Month, including some who are breast cancer patients.
Proper diet, exercise, weight control among factors that may help, experts say
With arrival of October comes plenty of pink on everything everywhere as part of Breast Cancer Awareness Month. So what better time to raise awareness about what’s helpful — and what’s not — when a friend, family member or acquaintance has cancer?
Study finds notable rise in number of women once considered at high risk for the procedure
Ten years ago, after successful treatment for breast cancer, anxiety became Susan Chase's constant companion. She was unable to sleep, and the unsettled feeling that "the sky was going to fall on me" plagued her daily life.
Contrary to media reports, researchers found no evidence wearing them boosted chances of disease
Drug should remain standard of care for HER2-positive tumors, doctors say
Study finds survivors more likely to need hospital care, antidepressants to cope than cancer-free women
Genetic variation also linked to less dense tissue
Taking drug in addition to chemotherapy also reduces risk of cancer recurrence
Proper diet, exercise, weight control among factors that may help, experts say
'Extra Help' program leads to more women on hormone therapy, study reports
Mastectomy patients benefit from lidocaine, study says
Breast cancer particularly troubling, researchers report
Study finds notable rise in number of women once considered at high risk for the procedure
Tumors in rodents exposed to dim light seemed to develop resistance to a common cancer drug
Tumors in rodents exposed to dim light seemed to develop resistance to a common cancer drug
Finding is yet another reason to maintain a healthy weight, experts say
Drug should remain standard of care for HER2-positive tumors, doctors say
Tumors in rodents exposed to dim light seemed to develop resistance to a common cancer drug
Women with HER2-positive tumors gained an average 16 more months of life with Perjeta, study finds